# Solriamfetol Hcl (Sunosi)

Source: https://ourhealthnetwork.com/drugs/solriamfetol-hcl
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Solriamfetol Hcl?

Solriamfetol Hcl (brand name: Sunosi) is a dopamine and norepinephrine reuptake inhibitor. It is prescribed to treat sleepiness. Across the United States, 515 doctors prescribe Solriamfetol to approximately 135 Medicare patients.

## Brand names

Sunosi

## Indications

Solriamfetol Hcl is primarily prescribed for the treatment of sleepiness.

## Conditions treated

- [Sleepiness](https://ourhealthnetwork.com/conditions/sleepiness)

## Mechanism of action

The mechanism of action of solriamfetol to improve wakefulness in patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea is unclear. However, its efficacy could be mediated through its activity as a dopamine and norepinephrine reuptake inhibitor (DNRI).

## Drug classification

- Established Pharmacologic Class: Dopamine and Norepinephrine Reuptake Inhibitor [EPC]
- Mechanism of Action class: Dopamine Uptake Inhibitors [MoA]
- Route of administration: ORAL

## Common side effects

anxiety, decreased appetite, insomnia, nausea

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)